CVSA Form 144: Proposed Sale of 7,500 RSUs

CVSA filed a Form 144 notice reporting a proposed sale of 7,500 Restricted Stock Units held through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

CVSA filed a Form 144 notice reporting a proposed sale of 7,500 Restricted Stock Units held through Morgan Stanley Smith Barney LLC. The filing also records a prior 10b5-1 sale by Robert Phelan of 10,000 common shares on 05/08/2026 for $1,262,064.69.

The notice lists the securities type as Restricted Stock Units with a grant/vesting date of 08/24/2025 and identifies the broker and exchange information shown in the excerpt.

Insights

Securities Compliance Attorney

Form 144 documents proposed resale and records a recent 10b5-1 sale.

The filing notifies the market of a proposed sale of 7,500 Restricted Stock Units and discloses a prior 10b5-1 disposition of 10,000 shares on 05/08/2026 for $1,262,064.69. This is a routine regulatory notice required when certain resale conditions apply.

Timing and final execution details for the proposed sale are not present in the excerpt; subsequent filings or broker reports would show completion and cash‑flow treatment.

Key Figures

Restricted Stock Units proposed for resale: 7,500 shares 10b5-1 sale recorded: 10,000 shares Proceeds from 10b5-1 sale: $1,262,064.69

3 metrics

Restricted Stock Units proposed for resale 7,500 shares Restricted Stock Units dated 08/24/2025

10b5-1 sale recorded 10,000 shares Sale executed 05/08/2026 by Robert Phelan

Proceeds from 10b5-1 sale $1,262,064.69 Proceeds from 10,000-share sale on 05/08/2026

Key Terms

Form 144, 10b5-1, Restricted Stock Units

3 terms

Form 144 regulatory

"Form 144 notice reporting proposed resale and broker details"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for ROBERT PHELAN 233 South Wacker Drive"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Securities To Be Sold — Restricted Stock Units dated 08/24/2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

What does CVSA's Form 144 report?

The Form 144 reports a proposed resale of 7,500 Restricted Stock Units and references a prior 10b5-1 sale of 10,000 shares on 05/08/2026 that generated $1,262,064.69 in proceeds.

Who executed the recorded 10b5-1 sale in the filing?

The excerpt shows a 10b5-1 sale executed by Robert Phelan on 05/08/2026, disposing of 10,000 common shares for $1,262,064.69, as reported in the filing's sales section.

What securities are the proposed resale and their dated grant?

The proposed resale concerns Restricted Stock Units totaling 7,500 with an indicated date of 08/24/2025, listed in the filing under securities to be sold by the brokered account.

Does the filing state where shares trade or the broker used?

Yes; the excerpt references NYSE and identifies the broker as Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, included on the filer information portion of the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001802419
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Covista Inc.
SEC File Number	001-13988
Address of Issuer	233 South Wacker Drive Chicago ILLINOIS 60606
Phone	3126511400
Name of Person for Whose Account the Securities are To Be Sold	ROBERT PHELAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7500	971700.00	34030887	07/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/24/2025	Restricted Stock Units	Issuer			7500	08/24/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ROBERT PHELAN 233 South Wacker Drive Chicago IL 60606	Common	05/08/2026	10000	1262064.69

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Phelan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)